AB Science S.A. | Mutual Funds

Mutual Funds that own AB Science S.A.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
CREF Stock Account
51,671
0.13%
0
0%
03/31/2018
IGNI - Titan
40,000
0.1%
0
0.73%
09/30/2017
PWM Vermoegensfondsmandat - DWS - High Conviction Equity (EUR)
21,000
0.05%
-9,000
0.1%
07/31/2018
Lyxor UCITS ETF PEA PME
20,854
0.05%
0
0.96%
09/05/2018
20,000
0.05%
0
0.14%
06/30/2017
SPDR S&P International Small Cap ETF
14,064
0.03%
0
0.01%
09/06/2018
Tredje AP Fonden
13,669
0.03%
0
0%
06/30/2017
7,933
0.02%
0
0%
12/29/2017
CCR Actions Biotech
4,000
0.01%
1,000
0.12%
12/30/2016
Arcalis
2,044
0.01%
-622
0%
12/31/2015

About AB Science

View Profile
Address
3, Avenue George V
Paris Ile-de-France 75008
France
Employees -
Website http://www.ab-science.com
Updated 07/08/2019
AB Science SA engages in the research, development, and sales of protein kinase inhibitor drugs. It develops pharmaceutical products for the treatment of cancer, neurological, and inflammatory diseases. The firm also engages in the field of veterinary medicine.